Lifecore Financial Statements From 2010 to 2026

LFCR Stock   8.22  0.12  1.48%   
Lifecore Biomedical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Lifecore Biomedical's valuation are provided below:
Gross Profit
40.3 M
Profit Margin
(0.30)
Market Capitalization
308 M
Enterprise Value Revenue
3.2985
Revenue
128.9 M
There are over ninety available fundamental ratios for Lifecore Biomedical, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to check Lifecore Biomedical's last-minute fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction.

Lifecore Biomedical Total Revenue

274.59 Million

Check Lifecore Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 26.4 M or Total Revenue of 274.6 M, as well as many indicators such as Price To Sales Ratio of 0.2, Dividend Yield of 0.0 or PTB Ratio of 0.67. Lifecore financial statements analysis is a perfect complement when working with Lifecore Biomedical Valuation or Volatility modules.
  
Build AI portfolio with Lifecore Stock
Check out the analysis of Lifecore Biomedical Correlation against competitors.
To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

Lifecore Biomedical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets247.3 M275.2 M324.8 M
Pretty Stable
Short and Long Term Debt Total158 M150.4 M113.7 M
Slightly volatile
Total Current Liabilities57.3 M34.7 M72.9 M
Pretty Stable
Total Stockholder Equity1.5 M1.5 M140.7 M
Slightly volatile
Property Plant And Equipment Net78.1 M148.4 M119.1 M
Slightly volatile
Accounts PayableM9.5 M23.9 M
Slightly volatile
Cash10.4 M7.4 MM
Slightly volatile
Non Current Assets Total161.4 M176.7 M225.8 M
Very volatile
Cash And Short Term Investments12.8 M7.4 M8.3 M
Slightly volatile
Common Stock Shares Outstanding26.8 M40 M28.4 M
Slightly volatile
Liabilities And Stockholders Equity247.3 M275.2 M324.8 M
Pretty Stable
Non Current Liabilities Total251 M239 M114.3 M
Slightly volatile
Inventory25.5 M37.1 M35.3 M
Slightly volatile
Other Current Assets1.6 M1.7 M10.8 M
Very volatile
Other Stockholder Equity126.3 M237.5 M151.2 M
Slightly volatile
Total Liabilities287.4 M273.7 M186 M
Slightly volatile
Total Current Assets85.9 M98.5 M99 M
Slightly volatile
Short Term Debt4.2 M4.4 M28.6 M
Pretty Stable
Net Receivables34.1 M50.2 M44 M
Pretty Stable
Intangible Assets3.6 M3.8 M26.8 M
Slightly volatile
Common Stock31.6 K33.3 K4.6 M
Slightly volatile
Current Deferred Revenue3.2 M3.1 M1.5 M
Slightly volatile
Short Term Investments1.7 M1.8 M1.6 M
Very volatile
Good Will11.9 M12.5 M38 M
Slightly volatile
Other LiabilitiesM3.1 M13.5 M
Slightly volatile
Other Assets25.1 M17.8 M15.8 M
Pretty Stable
Long Term Debt125.7 M146 M104.1 M
Slightly volatile
Capital Lease Obligations330.9 K348.3 K7.4 M
Pretty Stable
Net Invested Capital211.2 M118.6 M325.3 M
Slightly volatile
Long Term Investments43.5 M40.6 M53.9 M
Slightly volatile
Short and Long Term Debt2.9 M3.1 M42.7 M
Slightly volatile
Capital Stock33.6 K42.5 K30.7 K
Slightly volatile
Non Current Liabilities Other11.8 M11.2 M3.8 M
Slightly volatile
Property Plant Equipment132.6 M121.1 M173.6 M
Slightly volatile
Property Plant And Equipment Gross143.9 M167.8 M197.1 M
Slightly volatile

Lifecore Biomedical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization8.1 M9.2 M10.7 M
Slightly volatile
Interest Expense26.4 M25.1 M9.2 M
Slightly volatile
Total Revenue274.6 M148.2 M304.2 M
Slightly volatile
Gross Profit46.6 M46.3 M53 M
Pretty Stable
Other Operating Expenses269.6 M168 M302.3 M
Slightly volatile
Research Development7.1 M9.5 M8.3 M
Pretty Stable
Cost Of Revenue96.8 M101.9 M243.4 M
Slightly volatile
Total Operating Expenses41.7 M66.2 M51.2 M
Slightly volatile
Selling General Administrative41.1 M39.6 M46.9 M
Pretty Stable
Selling And Marketing Expenses4.4 K4.6 K659.2 K
Slightly volatile
Interest Income71.2 K61.2 K110.2 K
Slightly volatile
Reconciled Depreciation11.7 M7.2 M14.3 M
Slightly volatile

Lifecore Biomedical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow11 M7.6 M8.5 M
Pretty Stable
Depreciation8.2 M9.2 M10.8 M
Slightly volatile
Capital Expenditures16.5 M15.4 M21.3 M
Pretty Stable
End Period Cash Flow10.8 M7.4 M8.1 M
Slightly volatile
Dividends Paid2.6 M2.8 M6.3 M
Slightly volatile
Change To Netincome31.8 M37 M17.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.20.21431.6265
Slightly volatile
PTB Ratio0.670.7014155
Slightly volatile
Days Sales Outstanding44.3446.7044114
Slightly volatile
Book Value Per Share3.823.16660.4448
Slightly volatile
Stock Based Compensation To Revenue0.0350.03330.0736
Slightly volatile
Capex To Depreciation0.690.72741.558
Slightly volatile
PB Ratio0.670.7014155
Slightly volatile
EV To Sales0.250.26722.4717
Slightly volatile
Inventory Turnover13.1711.15483.851
Slightly volatile
Days Of Inventory On Hand23.1224.3333120
Slightly volatile
Payables Turnover11.7313.187510.9729
Slightly volatile
Sales General And Administrative To Revenue0.0760.10.096
Slightly volatile
Research And Ddevelopement To Revenue0.0190.020.0588
Slightly volatile
Capex To Revenue0.01320.01390.0934
Slightly volatile
Cash Per Share0.810.43190.2825
Slightly volatile
Days Payables Outstanding34.7427.677633.5616
Slightly volatile
Income Quality0.06450.06790.0125
Slightly volatile
Intangibles To Total Assets0.290.34770.1042
Slightly volatile
Current Ratio1.021.07562.6283
Slightly volatile
Receivables Turnover10.097.81513.6572
Slightly volatile
Shareholders Equity Per Share3.83.07960.4385
Slightly volatile
Debt To Equity0.30.313586.4373
Slightly volatile
Capex Per Share0.130.14010.3558
Slightly volatile
Revenue Per Share7.8610.0794.3209
Slightly volatile
Interest Debt Per Share0.920.96543.9794
Slightly volatile
Debt To Assets0.180.16270.5024
Slightly volatile
Graham Number5.63.62.2712
Slightly volatile
Operating Cycle10671.0377237
Slightly volatile
Price Book Value Ratio0.670.7014155
Slightly volatile
Price Earnings To Growth Ratio0.30.28420.0469
Slightly volatile
Days Of Payables Outstanding34.7427.677633.5616
Slightly volatile
Ebt Per Ebit0.150.15981.997
Slightly volatile
Company Equity Multiplier1.831.9263158
Slightly volatile
Long Term Debt To Capitalization0.08150.08580.883
Slightly volatile
Total Debt To Capitalization0.250.23870.9022
Slightly volatile
Debt Equity Ratio0.30.313586.4373
Slightly volatile
Quick Ratio0.80.84141.6575
Slightly volatile
Cash Ratio0.170.18160.2623
Slightly volatile
Cash Conversion Cycle70.9543.3601203
Slightly volatile
Days Of Inventory Outstanding23.1224.3333120
Slightly volatile
Days Of Sales Outstanding44.3446.7044114
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio27.5226.207961.5028
Slightly volatile
Price To Book Ratio0.670.7014155
Slightly volatile
Fixed Asset Turnover6.049.20281.778
Slightly volatile
Debt Ratio0.180.16270.5024
Slightly volatile
Price Sales Ratio0.20.21431.6265
Slightly volatile
Asset Turnover1.281.6990.6503
Slightly volatile
Gross Profit Margin0.260.17110.3013
Slightly volatile
Price Fair Value0.670.7014155
Slightly volatile

Lifecore Biomedical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap47.2 M49.6 M212.2 M
Slightly volatile
Enterprise Value41.2 M43.3 M319.6 M
Slightly volatile

Lifecore Fundamental Market Drivers

Forward Price Earnings8.673
Cash And Short Term Investments8.3 M

Lifecore Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
6th of June 2024
Next Financial Report
View
30th of November 2023
Next Fiscal Quarter End
View
29th of August 2024
Next Fiscal Year End
View
31st of August 2023
Last Quarter Report
View
31st of May 2023
Last Financial Announcement
View

About Lifecore Biomedical Financial Statements

Lifecore Biomedical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Lifecore Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Lifecore Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lifecore Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.1 M3.2 M
Total Revenue148.2 M274.6 M
Cost Of Revenue101.9 M96.8 M
Stock Based Compensation To Revenue 0.03  0.04 
Sales General And Administrative To Revenue 0.10  0.08 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.01  0.01 
Revenue Per Share 10.08  7.86 
Ebit Per Revenue 0.01  0.01 

Pair Trading with Lifecore Biomedical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifecore Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will appreciate offsetting losses from the drop in the long position's value.

Moving against Lifecore Stock

  0.8DRMA Dermata TherapeuticsPairCorr
  0.77RAC Race OncologyPairCorr
  0.68AVH Avita MedicalPairCorr
  0.67VANI Vivani MedicalPairCorr
  0.47VALN Valneva SE ADRPairCorr
The ability to find closely correlated positions to Lifecore Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifecore Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifecore Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifecore Biomedical to buy it.
The correlation of Lifecore Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifecore Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifecore Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifecore Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Lifecore Stock Analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.